The DOI matches its Crossref record; 237 of the 237 references it cites were found in a registry or an index.
Antifungal Drug Resistance: Molecular Mechanisms in Candida albicans and Beyond
Open accessAbstract
Fungal infections are a major contributor to infectious disease-related deaths across the globe. Candida species are among the most common causes of invasive mycotic disease, with Candida albicans reigning as the leading cause of invasive candidiasis. Given that fungi are eukaryotes like their human host, the number of unique molecular targets that can be exploited for antifungal development remains limited. Currently, there are only three major classes of drugs approved for the treatment of invasive mycoses, and the efficacy of these agents is compromised by the development of drug resistance in pathogen populations. Notably, the emergence of additional drug-resistant species, such as Candida auris and Candida glabrata, further threatens the limited armamentarium of antifungals available to treat these serious infections. Here, we describe our current arsenal of antifungals and elaborate on the resistance mechanisms Candida species possess that render them recalcitrant to therapeutic intervention. Finally, we highlight some of the most promising therapeutic strategies that may help combat antifungal resistance, including combination therapy, targeting fungal-virulence traits, and modulating host immunity. Overall, a thorough understanding of the mechanistic principles governing antifungal drug resistance is fundamental for the development of novel therapeutics to combat current and emerging fungal threats.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In addition, large-scale genomic alterations, including aneuploidy, loss-of-heterozygosity (LOH), and chromosomal rearrangements, can affect the expression of drug targets, efflux pumps, and other resistance factors (7).”
From Potential role of lysine acetylation in the stepwise adaptation of Candida albicans to fluconazole (2025) · cites this paper as [7]
The cited source says what the claim attributes to it.
In the citing paper
“These mutations lead to either the overexpression of the enzyme itself (14) or alterations in its activity that can lower fluconazole’s binding strength, leading to reduced drug effectiveness (15).”
From Candida albicans enhances iron uptake to maintain fluconazole resistance (2025) · cites this paper as [15]
In the citing paper
“the only new class of antifungal drugs developed in decades, the echinocandins, displays negligible antifungal activity against Cryptococcus spp.”
From Treatment strategies for cryptococcal infection: challenges, advances and future outlook (2021) · cites this paper as [2]
In the citing paper
“Treatment options for invasive cryptococcal infection are limited, given that Cryptococcus spp. are intrinsically resistant to echinocandins and that they employ an arsenal of defences that enable resistance to azoles2,8.”
From Treatment strategies for cryptococcal infection: challenges, advances and future outlook (2021) · cites this paper as [2]
In the citing paper
“the polyene amphotericin B has been the primary treatment for cryptococcal infection for more than half a century, despite the fact that it causes substantial toxicity and that its availability is limited by economic and logistical constraints2,4”
From Treatment strategies for cryptococcal infection: challenges, advances and future outlook (2021) · cites this paper as [2]
In the citing paper
“current antifungal drug treatments for invasive fungal infections are limited to polyenes, azoles and echinocandins2”
From Treatment strategies for cryptococcal infection: challenges, advances and future outlook (2021) · cites this paper as [2]
In the citing paper
“Combination therapy has the potential to confer enhanced efficacy and fungal selectivity while reducing vulnerability to the evolution of resistance2.”
From Treatment strategies for cryptococcal infection: challenges, advances and future outlook (2021) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lead- and drug-like compounds: the rule-of-five revolution
Lipinski, C. A. (2004) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2004.11.007 · Cited by 6,455
Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421946 · Cited by 4,496
Hidden Killers: Human Fungal Infections
Brown, G. D., Denning, D. W., Gow, N. A. R., Levitz, S. M., Netea, M. G., & White, T. C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004404 · Cited by 4,284
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174
The Genetic Landscape of a Cell
Costanzo, M., Baryshnikova, A., Bellay, J., Kim, Y., Spear, E. D., Sevier, C. S., Ding, H., Koh, J. L. Y., Toufighi, K., Mostafavi, S., et al. (2010) · Science · doi:10.1126/science.1180823 · Cited by 2,162
Candida albicans pathogenicity mechanisms
Mayer, F. L., Wilson, D., & Hube, B. (2013) · Virulence · doi:10.4161/viru.22913 · Cited by 1,848
HSP90 at the hub of protein homeostasis: emerging mechanistic insights
Taipale, M., Jarosz, D. F., & Lindquist, S. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2918 · Cited by 1,818
Lockhart, S. R., Etienne, K. A., Vallabhaneni, S., Farooqi, J., Chowdhary, A., Govender, N. P., Colombo, A. L., Calvo, B., Cuomo, C. A., Desjardins, C. A., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw691 · Cited by 1,662
Worldwide emergence of resistance to antifungal drugs challenges human health and food security
Fisher, M. C., Hawkins, N. J., Sanglard, D., & Gurr, S. J. (2018) · Science · doi:10.1126/science.aap7999 · Cited by 1,555
Flagged first, then by citations
Research works printed but not linked: 1
- Besterman, J.; Nguyen, D. T.; Ste-Croix, H. MGCD290, an Oral Fungal Hos2 Inhibitor, Enhances the Antifungal Properties of Fluconazole Following Multiple-or Single-Dose Oral Administration in Pre-and Post-Infection Settings. In Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) ; MethylGene, Inc.: San Francisco, CA, 2012; Vol. Poster M-1711.
Cited by
Sorted by citations
Treatment strategies for cryptococcal infection: challenges, advances and future outlook
Iyer, K. R., Revie, N. M., Fu, C., Robbins, N., & Cowen, L. E. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00511-0 · Cited by 363
Self-citationAntifungal drug-resistance mechanisms in Candida biofilms
Kaur, J., & Nobile, C. J. (2022) · Current Opinion in Microbiology · doi:10.1016/j.mib.2022.102237 · Cited by 279
Geng, C., He, S., Yu, S., Johnson, H. M., Shi, H., Chen, Y., Chan, Y. K., He, W., Qin, M., Li, X., et al. (2024) · Advanced Materials · doi:10.1002/adma.202310599 · Cited by 252
The importance of antimicrobial resistance in medical mycology
Gow, N. A. R., Johnson, C., Berman, J. G., Coste, A. T., Cuomo, C. A., Perlin, D. S., Bicanic, T. A., Harrison, T. S., Wiederhold, N. P., Bromley, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32249-5 · Cited by 232
Mechanisms of Antifungal Properties of Metal Nanoparticles
Slavin, Y. N., & Bach, H. (2022) · Nanomaterials · doi:10.3390/nano12244470 · Cited by 222
Cryptococcus neoformans, a global threat to human health
Zhao, Y., Ye, L., Zhao, F., Zhang, L., Lu, Z., Chu, T., Wang, S., Liu, Z., Sun, Y., Chen, M., et al. (2023) · Infectious Diseases of Poverty · doi:10.1186/s40249-023-01073-4 · Cited by 217
Current Progress on Epidemiology, Diagnosis, and Treatment of Sporotrichosis and Their Future Trends
Rodrigues, A. M., Gonçalves, S. S., de Carvalho, J. A., Borba-Santos, L. P., Rozental, S., & Camargo, Z. P. D. (2022) · Journal of Fungi · doi:10.3390/jof8080776 · Cited by 187
D-Limonene: Promising and Sustainable Natural Bioactive Compound
Lin, H., Li, Z., Sun, Y., Zhang, Y., Wang, S., Zhang, Q., Cai, T., Xiang, W., Zeng, C., & Tang, J. (2024) · Applied Sciences · doi:10.3390/app14114605 · Cited by 168
Tang, Y., Varyambath, A., Ding, Y., Chen, B., Huang, X., Zhang, Y., Yu, D., Kim, I., & Song, W. (2022) · Biomaterials Science · doi:10.1039/d2bm00719c · Cited by 136
A probiotic nanozyme hydrogel regulates vaginal microenvironment for Candida vaginitis therapy
Wei, G., Liu, Q., Wang, X., Zhou, Z., Zhao, X., Zhou, W., Liu, W., Zhang, Y., Liu, S., Zhu, C., et al. (2023) · Science Advances · doi:10.1126/sciadv.adg0949 · Cited by 137
Antifungals and Drug Resistance
Hossain, C. M., Ryan, L. K., Gera, M., Choudhuri, S., Lyle, N., Ali, K. A., & Diamond, G. (2022) · Encyclopedia · doi:10.3390/encyclopedia2040118 · Cited by 135
Advancements and challenges in antifungal therapeutic development
Puumala, E., Fallah, S., Robbins, N., & Cowen, L. E. (2024) · Clinical Microbiology Reviews · doi:10.1128/cmr.00142-23 · Cited by 128
Self-citationAzizah, N. S., Irawan, B., Kusmoro, J., Safriansyah, W., Farabi, K., Oktavia, D., Doni, F., & Miranti, M. (2023) · Plants · doi:10.3390/plants12244148 · Cited by 117
Antifungals: From Pharmacokinetics to Clinical Practice
do Carmo, A., Rocha, M. J., Pereirinha, P., Tomé, R., & Costa, E. (2023) · Antibiotics · doi:10.3390/antibiotics12050884 · Cited by 115
MacAlpine, J., Daniel-Ivad, M., Liu, Z., Yano, J., Revie, N. M., Todd, R. T., Stogios, P. J., Sánchez, H., O’Meara, T. R., Tompkins, T. A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26390-w · Cited by 111
Self-citationJi, X., Yang, H., Liu, W., Ma, Y., Wu, J., Zong, X., Yuan, P., Chen, X., Yang, C., Li, X., et al. (2021) · ACS Nano · doi:10.1021/acsnano.1c01379 · Cited by 103
Photodynamic disinfection and its role in controlling infectious diseases
Aroso, R. T., Scháberle, F. A., Arnaut, L. G., & Pereira, M. M. (2021) · Photochemical & Photobiological Sciences · doi:10.1007/s43630-021-00102-1 · Cited by 94
Zheng, L., Zhu, Y., Sun, Y., Xia, S., Duan, S., Yu, B., Li, J. Y., & Xu, F. (2023) · Advanced Materials · doi:10.1002/adma.202302943 · Cited by 93
Guo, J., Jiang, X., Tian, Y., Yan, S., Liu, J., Xie, J., Zhang, F., Yao, C., & Hao, E. (2024) · Pharmaceuticals · doi:10.3390/ph17121700 · Cited by 91
Yassin, M. T., Mostafa, A. A.-F., Al-Askar, A. A., & Al-Otibi, F. O. (2022) · Crystals · doi:10.3390/cryst12060774 · Cited by 96
Frei, A., Elliott, A. G., Kan, A. E., Dinh, H., Bräse, S., Bruce, A. E., Bruce, M. R. M., Chen, F., Humaidy, D., Jung, N., et al. (2022) · JACS Au · doi:10.1021/jacsau.2c00308 · Cited by 90
The role of Candida albicans stress response pathways in antifungal tolerance and resistance
Iyer, K. R., Robbins, N., & Cowen, L. E. (2022) · iScience · doi:10.1016/j.isci.2022.103953 · Cited by 88
Self-citationJiang, W., Zhou, M., Cong, Z., Xie, J., Zhang, W., Chen, S., Zou, J., Ji, Z., Shao, N., Chen, X., et al. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202200778 · Cited by 88
Fu, C., Zhang, X., Veri, A. O., Iyer, K. R., Lash, E., Xue, A., Yan, H., Revie, N. M., Wong, C. J., Lin, Z., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26850-3 · Cited by 90
Self-citationRecent Progress in the Discovery of Antifungal Agents Targeting the Cell Wall
Liu, W., Yuan, L., & Wang, S. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00748 · Cited by 81
Nanoparticles for Antimicrobial Agents Delivery—An Up-to-Date Review
Mercan, D.-A., Niculescu, A.-G., & Grumezescu, A. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213862 · Cited by 77
Shahina, Z., Homsi, R. A., Price, J. D. W., Whiteway, M. S., Sultana, T., & Dahms, T. E. S. (2022) · PLoS ONE · doi:10.1371/journal.pone.0277097 · Cited by 75
Chen, L., Zhang, L., Xie, Y., Wang, Y., Tian, X., Fang, W., Xue, X., & Wang, L. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115007 · Cited by 63
New antifungal strategies: Drug combination and co-delivery
Zhu, P., Li, Y., Guo, T., Liu, S., Tancer, R. J., Hu, C., Zhao, C., Xue, C., & Liao, G. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114874 · Cited by 63
Li, C., Tu, J., Han, G., Liu, N., & Sheng, C. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113961 · Cited by 61
Sui, Y., Ansari, M. F., Fang, B., Zhang, S., & Zhou, C. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113557 · Cited by 59
Monika, P., Chandraprabha, M. N., Krishna, R. H., Vittal, M., Likhitha, C., Pooja, N., Chaudhary, V., & Manjunatha, C. (2022) · Biotechnology and Genetic Engineering Reviews · doi:10.1080/02648725.2022.2122299 · Cited by 59
Martins‐Santana, L., Rezende, C. P., Rossi, A., Martinez-Rossi, N. M., & Almeida, F. B. D. R. (2023) · Pathogens · doi:10.3390/pathogens12020293 · Cited by 59
Chitosan-based systems aimed at local application for vaginal infections
Araújo, V. H. S., de Souza, M. P. C., Carvalho, G. C., Duarte, J. L., & Chorilli, M. (2021) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2021.117919 · Cited by 58
Garvey, M., Meade, E., & Rowan, N. J. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.158284 · Cited by 56
Wang, M., Tang, H., Wang, S., Hu, W., Li, J., Yu, A., Bai, Q.-X., Yang, B., & Kuang, H. (2023) · Molecules · doi:10.3390/molecules28114525 · Cited by 53
Häkkinen, S. T., Sokóvić, M., Nohynek, L. J., Ćirić, A., Ivanov, M., Stojković, D. S., Tsitko, I. V., Matos, M. S., Baixinho, J. P., Ivasiv, V., et al. (2021) · Pharmaceuticals · doi:10.3390/ph14090941 · Cited by 56
Pan- and isoform-specific inhibition of Hsp90: Design strategy and recent advances
Yu, J., Zhang, C., & Song, C. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114516 · Cited by 51
Roles of Hsp90 in Candida albicans morphogenesis and virulence
Robbins, N., & Cowen, L. E. (2023) · Current Opinion in Microbiology · doi:10.1016/j.mib.2023.102351 · Cited by 53
Self-citationToxic eburicol accumulation drives the antifungal activity of azoles against Aspergillus fumigatus
Elsaman, H., Golubtsov, E., Brazil, S., Ng, N., Klugherz, I., Martin, R., Dichtl, K., Müller, C., & Wagener, J. (2024) · Nature Communications · doi:10.1038/s41467-024-50609-1 · Cited by 50
Natural and synthetic β-carboline as a privileged antifungal scaffolds
Dai, J., Dan, W., & Wan, J. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.114057 · Cited by 49
Characterizations of the Gut Bacteriome, Mycobiome, and Virome in Patients with Osteoarthritis
Chen, C., Zhang, Y., Yao, X., Li, S., Wang, G., Huang, Y., Yang, Y., Zhang, A., Liu, C., Zhu, D., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01711-22 · Cited by 49
CRISPR-Based Genetic Manipulation of Candida Species: Historical Perspectives and Current Approaches
Uthayakumar, D., Sharma, J., Wensing, L. F., & Shapiro, R. S. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2020.606281 · Cited by 53
An, X., Erramilli, S., & Reinhard, B. M. (2021) · Nanoscale · doi:10.1039/d0nr08353d · Cited by 48
Nanomaterials-mediated photodynamic therapy and its applications in treating oral diseases
Yan, R., Liu, J., Dong, Z., & Peng, Q. (2022) · Biomaterials Advances · doi:10.1016/j.bioadv.2022.213218 · Cited by 47
Antifungal Activity of Mycogenic Silver Nanoparticles on Clinical Yeasts and Phytopathogens
Ribeiro, L. G., Roque, G. S. C., Conrado, R., & de Souza, A. O. (2023) · Antibiotics · doi:10.3390/antibiotics12010091 · Cited by 47
Zhang, R. Z., Zhang, R. X., Wang, S., Xu, C., Guan, W., & Wang, M. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202110749 · Cited by 47
Zolin, G. V. S., da Fonseca, F. H., Zambom, C. R., & Garrido, S. S. (2021) · Biomolecules · doi:10.3390/biom11081209 · Cited by 47
The emerging role of neutrophil extracellular traps in fungal infection
Liang, C.-T., Lian, N., & Li, M. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.900895 · Cited by 48
Affinity molecular assay for detecting Candida albicans using chitin affinity and RPA-CRISPR/Cas12a
Shen, S., Wang, W., Ma, Y., Wang, S., Zhang, S., Cai, X.-F., Chen, L., Zhang, J., Li, Y., Wu, X., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53693-5 · Cited by 46
Candidiasis: Insights into Virulence Factors, Complement Evasion and Antifungal Drug Resistance
Gaffar, N. R., Valand, N., & Girija, U. V. (2025) · Microorganisms · doi:10.3390/microorganisms13020272 · Cited by 50
Dhasarathan, P., AlSalhi, M. S., Devanesan, S., Subbiah, J., Ranjitsingh, A. J. A., Binsalah, M. A., & Alfuraydi, A. A. (2021) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2021.11.002 · Cited by 48
Zhou, Y., Yang, X., Chen, G., Zhu, F., Wang, J., Qi, Y., Huang, K., Wu, J., Chen, R., & Liu, Y. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2023.146198 · Cited by 45
Bafghi, M. H., Zarrinfar, H., Darroudi, M., Zargar, M., & Nazari, R. (2022) · Letters in Applied Microbiology · doi:10.1111/lam.13667 · Cited by 47
Kuliš, E., Cvitković, I., Pavlović, N., Kumrić, M., Rušić, D., & Božić, J. (2025) · Antibiotics · doi:10.3390/antibiotics14080828 · Cited by 46
Microbial Metabolite Inspired β‐Peptide Polymers Displaying Potent and Selective Antifungal Activity
Zhang, D., Shi, C., Cong, Z., Chen, Q., Bi, Y., Zhang, J., Ma, K., Liu, S., Gu, J., Chen, M., et al. (2022) · Advanced Science · doi:10.1002/advs.202104871 · Cited by 45
Molecular Diagnostics for Invasive Fungal Diseases: Current and Future Approaches
Pham, D., Sivalingam, V., Tang, H. M., Montgomery, J. M., Chen, S. C. ‐., & Halliday, C. L. (2024) · Journal of Fungi · doi:10.3390/jof10070447 · Cited by 47
Onohuean, H., Bukke, S. P. N., Thalluri, C., Abass, K. S., & Choonara, Y. E. (2025) · Frontiers in Medical Technology · doi:10.3389/fmedt.2025.1655471 · Cited by 43
Zhu, T., Chen, X., Li, C., Tu, J., Liu, N., Xu, D., & Sheng, C. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113524 · Cited by 43
Emerging and future strategies in the management of recalcitrant Candida auris
Bandara, N., & Samaranayake, L. P. (2022) · Medical Mycology · doi:10.1093/mmy/myac008 · Cited by 42
Vaccines against candidiasis: Status, challenges and emerging opportunity
Sahu, S. R., Bose, S., Singh, M. K., Kumari, P., Dutta, A., Utkalaja, B. G., Patel, S. K., & Acharya, N. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1002406 · Cited by 41
Fungal resilience and host–pathogen interactions: Future perspectives and opportunities
Brown, A. J. P. (2022) · Parasite Immunology · doi:10.1111/pim.12946 · Cited by 41
Antifungal activity of vitamin D3 against Candida albicans in vitro and in vivo
Lei, J., Xiao, W., Zhang, J., Liu, F., Xin, C., Zhou, B., Chen, W., & Song, Z. (2022) · Microbiological Research · doi:10.1016/j.micres.2022.127200 · Cited by 39
Fluconazole-COX Inhibitor Hybrids: A Dual-Acting Class of Antifungal Azoles
Elias, R., Basu, P., & Fridman, M. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01807 · Cited by 39
ROS‐Modulating Bio‐Heterojunction Nanosheets for Infected Wound Healing via Nanozyme Activity
Cui, F.-H., Fu, W., Chang, Q., Wang, J., Xie, Y., & Deng, X. (2025) · Small · doi:10.1002/smll.202412441 · Cited by 39
Molecular Dynamics Investigations of Binding Mechanism for Triazoles Inhibitors to CYP51
Shi, N., Zheng, Q., & Zhang, H. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.586540 · Cited by 40
Suppression of hyphal formation and virulence of Candida albicans by natural and synthetic compounds
Khan, F., Bamunuarachchi, N. I., Tabassum, N., Jo, D., Khan, P. D. M. M., & Kim, Y. (2021) · Biofouling · doi:10.1080/08927014.2021.1948538 · Cited by 38
Natural Polyketides Act as Promising Antifungal Agents
Wang, L., Lu, H., & Jiang, Y. (2023) · Biomolecules · doi:10.3390/biom13111572 · Cited by 37
New antifungal strategies and drug development against WHO critical priority fungal pathogens
Li, Y., Liu, Y., Jiang, Y., Yang, Y., Ni, W., Zhang, W., & Tan, L. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1662442 · Cited by 38
Harley, B. K., Quagraine, A. M., Neglo, D., Aggrey, M. O., Orman, E., Mireku-Gyimah, N. A., Amengor, C. D. K., Jato, J., Saaka, Y., & Fleischer, T. C. (2022) · PLoS ONE · doi:10.1371/journal.pone.0278096 · Cited by 37
Kukurudz, R. J., Chapel, M., Wonitowy, Q., Adamu Bukari, A.-R., Sidney, B., Sierhuis, R., & Gerstein, A. C. (2022) · G3 · doi:10.1093/g3journal/jkac156 · Cited by 35
Miranda, F., Tavares, V. K. F., Gomes, M. P., Neto, N. F. A., Chiappim, W., Petraconi, G., Pessoa, R. S., & Koga‐Ito, C. Y. (2023) · Water · doi:10.3390/w15234045 · Cited by 36
Shahabudin, S., Azmi, N. S., Lani, M. N., Mukhtar, M., & Hossain, M. S. (2024) · Mycoses · doi:10.1111/myc.13753 · Cited by 39
Lee, J., Kim, Y., Park, I., & Lee, J. (2024) · Biofilm · doi:10.1016/j.bioflm.2024.100218 · Cited by 35
The evolution of antifungal therapy: Traditional agents, current challenges and future perspectives
de Souza, C. M., Bezerra, B. T., Mellon, D. A., & de Oliveira, H. C. (2025) · Current Research in Microbial Sciences · doi:10.1016/j.crmicr.2025.100341 · Cited by 35
Yassin, M. T., Mostafa, A. A.-F., Al-Askar, A. A., & Al-Otibi, F. O. (2022) · Crystals · doi:10.3390/cryst12060816 · Cited by 38
Ferreira, R. L., Muniz, W., Souza, L. E. A., Navarro, H. M. C., de Mello, L. R., Mastelaro, V. R., Sales, T. O., Barbosa, C. D. A. D. E. S., Ribeiro, A. S., da Silva, E. R., et al. (2023) · ACS Applied Bio Materials · doi:10.1021/acsabm.3c00541 · Cited by 34
Current knowledge of vertebral osteomyelitis: a review
Zou, X., Li, X., He, K., Song, Q., & Yin, R. (2024) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-024-04983-9 · Cited by 34
Butassi, E., Svetaz, L. A., Carpinella, M. C., Efferth, T., & Zacchino, S. A. (2021) · Antibiotics · doi:10.3390/antibiotics10091053 · Cited by 34
Novel Promising Antifungal Target Proteins for Conquering Invasive Fungal Infections
Zhen, C., Lu, H., & Jiang, Y. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.911322 · Cited by 35
Liang, X., Chen, D., Wang, J., Liao, B., Shen, J., Ye, X., Wang, Z., Zhu, C., Gou, L., Zhou, X., et al. (2023) · International Journal of Oral Science · doi:10.1038/s41368-023-00245-0 · Cited by 32
Kumar, G., Kumar, P., Soni, A., Sharma, V., & Nemiwal, M. (2024) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2024.138289 · Cited by 34
Xing, Y., Liu, Y., Sha, S., Zhang, Y., Dou, Y., Liu, C., Xu, M., Zhao, L., Wang, J., Wang, Y., et al. (2024) · Journal of Medical Virology · doi:10.1002/jmv.29781 · Cited by 32
Nanomaterial-based therapeutics for enhanced antifungal therapy
Liu, F., Chen, Y., Huang, Y., Jin, Q., & Ji, J. (2024) · Journal of Materials Chemistry B · doi:10.1039/d4tb01484g · Cited by 33
Mechanisms of Azole Resistance and Trailing in Candida tropicalis Bloodstream Isolates
Chen, P., Chuang, Y., Wu, U., Sun, H., Wang, J., Sheng, W., Chen, Y., & Chang, S. (2021) · Journal of Fungi · doi:10.3390/jof7080612 · Cited by 32
Fu, C., Beattie, S. R., Jezewski, A. J., Robbins, N., Whitesell, L., Krysan, D. J., & Cowen, L. E. (2022) · Genetics · doi:10.1093/genetics/iyab164 · Cited by 31
Self-citationFungal Enzyme‐Responsive Hydrogel Drug Delivery Platform for Triggered Antifungal Release
Vera‐González, N., Deusenbery, C. B., LaMastro, V., & Shukla, A. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202401157 · Cited by 31
Antifungal Mechanism of Natural Products Derived from Plants: A Review
Long, N., & Li, F. (2024) · Natural Product Communications · doi:10.1177/1934578x241271747 · Cited by 32
Jaber, Q. Z., Bibi, M., Księżopolska, E., Gabaldón, T., Berman, J. G., & Fridman, M. (2020) · ACS Central Science · doi:10.1021/acscentsci.0c00813 · Cited by 32
Sun, A., Chai, N., Zhu, X., Li, Y., Wang, R., Zhang, Y., & Mao, Z. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115782 · Cited by 30
Niño‐Vega, G. A., Padró-Villegas, L., & López-Romero, E. (2024) · Journal of Fungi · doi:10.3390/jof10120871 · Cited by 33
Effects of Hsp90 Inhibitor Ganetespib on Inhibition of Azole-Resistant Candida albicans
Yuan, R., Tu, J., Sheng, C., Chen, X., & Liu, N. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.680382 · Cited by 30
Photosensitizers with Aggregation-induced Emission and Their Biomedical Applications
Chen, L., Wang, X., Yuan, Y., Hu, R., Chen, Q., Zhu, L., Gu, M., & Shen, C. (2022) · Engineered Regeneration · doi:10.1016/j.engreg.2022.01.005 · Cited by 30
Development of Lipo-γ-AA Peptides as Potent Antifungal Agents
Zhang, X., Wang, M., Zhu, X., Peng, Y., Fu, T., Hu, C., Cai, J., & Liao, G. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00595 · Cited by 30
Sun, C., Zhao, X., Jiao, Z.-L., Peng, J., Zhou, L., Yang, L., Huang, M., Tian, C., & Guo, G. (2022) · Antibiotics · doi:10.3390/antibiotics11111474 · Cited by 30
Gu, K., Feng, S., Zhang, X., Peng, Y., Sun, P., Liu, W., Wu, Y., Yu, Y., Liu, X., Liu, X., et al. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117156 · Cited by 29
Ramesh, S., Roy, U., Roy, S., & Rudramurthy, S. M. (2024) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-023-12976-5 · Cited by 30
Targeting Fks1 proteins for novel antifungal drug discovery
Kumar, V., Huang, J., Dong, Y., & Hao, G. (2024) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2024.02.007 · Cited by 30
Ding, J., Yan, Z., Peng, L., Li, J., Yang, F., & Zheng, D. (2024) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-024-04223-4 · Cited by 29
AI in fungal drug development: opportunities, challenges, and future outlook
Li, Y., Qiao, Y., Ma, Y., Xue, P., & Ding, C. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1610743 · Cited by 30
Metadata
- Authors
- Lee, Y., Puumala, E., Robbins, N., & Cowen, L. E.
- Affiliations
- University of Toronto (CA)
- Corresponding author
- Cowen, Leah E.
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2020-05-22
- Volume
- 121
- Issue
- 6
- Pages
- 3390-3411
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- PMC
- PMC8519031
- OpenAlex
- W3026958586
- Cited by
- 801
- References
- 237
- Citations by year
- 2026: 109 · 2025: 192 · 2024: 168 · 2023: 133 · 2022: 132 · 2021: 63 · 2020: 4
- FWCI
- 3.96
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Chemical Reviews (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Canadian Institutes of Health Research (FDN-154288)
- National Institute of Allergy and Infectious Diseases (1R01AI127375-01)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Keywords
- antifungal resistance, Candida albicans, Candida auris, Candida glabrata, invasive candidiasis, antifungal agents, molecular mechanisms of resistance, combination antifungal therapy, fungal virulence factors, emerging fungal pathogens
- MeSH terms
- Drug Development, Animals, Antifungal Agents, Candida, Candida albicans, Drug Therapy, Combination, Humans, Mycoses, Virulence, Molecular Structure, Signal Transduction, Drug Resistance, Fungal, Candida glabrata
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
